The idiopathic inflammatory myopathies are characterized by muscle weakness, skin
disease and internal organ involvement. Autoimmunity is known to have a role in myositis …

Background Psoriatic arthritis (PsA) is a clinically heterogeneous disease. Clear consensual
treatment guidance focused on the musculoskeletal manifestations of PsA would be …

Objective: To develop comprehensive recommendations for the treatment of the various
clinical manifestations of psoriatic arthritis (PsA) based on evidence obtained from a systematic …

… McHugh has received consulting fees, speaking fees, and/or honoraria from AbbVie, Amgen,
Pfizer… Soriano ER, McHugh NJ. Therapies for peripheral joint disease in psoriatic arthritis: a …

Objective The lack of randomized controlled trials (RCTs) in pulmonary fibrosis in systemic
sclerosis (SSc) has hampered an evidence‐based approach to treatment. This RCT was …

Objective. To devise a more discriminating version of the British Isles Lupus Assessment
Group (BILAG) disease activity index and to show that it is reliable. Methods. A nominal …

1.0 Background Psoriasis is a common, chronic inflammatory skin disease which typically
follows a relapsing and remitting course, and is associated with joint disease in approximately …

Objective. To assess the evolution of disease subgroups and the frequency of progression
of peripheral joint disease in a prospectively studied cohort of patients with psoriatic arthritis (…

… As the whole series is concerned, the regression coefficient between the score and the items
(n=152) ranged from 0.831 to 0.846 (mean 0.837; SE 0.0002; confidence interval (CI) 0.836 …

Psoriatic arthritis (PsA) is an inflammatory joint disease that is distinct from other chronic
arthritides and which is frequently accompanied by psoriasis vulgaris (PsV) and seronegativity …